Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Aclaris Therapeutics (LSE:0H8T) with a Sector Outperform recommendation.
https://www.nasdaq.com/articles/scotiabank-initiates-coverage-aclaris-therapeutics-lse-0h8t-sector-outperform